Press release year list 2020 2019 2018 2017 2016 2015
November 12, 2020
Aptinyx Reports Third Quarter 2020 Financial Results and Recent Highlights
Download PDF format download (opens in new window)
November 10, 2020
Aptinyx to Participate in Upcoming Virtual Investor Conferences
Download PDF format download (opens in new window)
October 29, 2020
Aptinyx to Report Third Quarter Financial Results on Thursday, November 12, 2020
Download PDF format download (opens in new window)
October 26, 2020
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Download PDF format download (opens in new window)
October 21, 2020
Aptinyx Announces Pricing of Public Offering of Common Stock
Download PDF format download (opens in new window)
October 20, 2020
Aptinyx Announces Proposed Public Offering of Common Stock
Download PDF format download (opens in new window)
October 19, 2020
Aptinyx Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder
Download PDF format download (opens in new window)
September 28, 2020
Aptinyx Recommences Patient Recruitment in Phase 2 Study of NYX-2925 in Patients with Fibromyalgia
Download PDF format download (opens in new window)
September 03, 2020
Aptinyx to Present at Upcoming Virtual Investor Conferences
Download PDF format download (opens in new window)
August 13, 2020
Aptinyx Reports Second Quarter 2020 Financial Results and Highlights
Download PDF format download (opens in new window)
August 04, 2020
Aptinyx to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
Download PDF format download (opens in new window)
July 30, 2020
Aptinyx to Report Second Quarter Financial Results on Thursday, August 13, 2020
Download PDF format download (opens in new window)
July 08, 2020
Aptinyx to Host PTSD-Focused R&D Day on August 5th, 2020
Download PDF format download (opens in new window)
June 26, 2020
Aptinyx to be Added to Russell 2000® Index
Download PDF format download (opens in new window)
June 18, 2020
Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder
Download PDF format download (opens in new window)
June 16, 2020
Aptinyx to Present at Upcoming Virtual Investor Conferences
Download PDF format download (opens in new window)
May 14, 2020
Aptinyx Reports First Quarter 2020 Financial Results and Highlights
Download PDF format download (opens in new window)
April 30, 2020
Aptinyx to Report First Quarter Financial Results on Thursday, May 14, 2020
Download PDF format download (opens in new window)
March 30, 2020
Aptinyx Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Download PDF format download (opens in new window)
March 18, 2020
Aptinyx to Report Fourth Quarter and Full Year 2019 Financial Results on Monday, March 30, 2020
Download PDF format download (opens in new window)
February 19, 2020
Aptinyx to Present at Upcoming Investor Conferences
Download PDF format download (opens in new window)
January 30, 2020
Aptinyx Announces Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson’s Disease
Download PDF format download (opens in new window)
January 14, 2020
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Download PDF format download (opens in new window)
January 10, 2020
Aptinyx Announces Pricing of Public Offering of Common Stock
Download PDF format download (opens in new window)
January 09, 2020
Aptinyx Announces Proposed Public Offering of Common Stock
Download PDF format download (opens in new window)